Inhibitory effect of igm rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation
Open Access
- 1 October 1984
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 27 (10) , 1130-1136
- https://doi.org/10.1002/art.1780271008
Abstract
Purified IgM rheumatoid factors (RF; 3 monoclonal and 2 polyclonal) were shown to inhibit, in a dosedependent manner, 2 complement-mediated functions, i.e., the immune complex solubilization capacity and the inhibition of immune precipitation. Inhibition of immune complex solubilization capacity occurred only if RF was added at the same time as, but not after, addition of the complement source. Experimental evidence suggests that the effects of RFs were not related to their anticomplementary activity, but rather required the attachment of RF to the Fc region of the IgG molecule. Although no clinical data are available so far, it might be plausible that these newly described properties of RF have biologic relevance.This publication has 14 references indexed in Scilit:
- Capacity to solubilize immune complexes in sera and synovial fluids from patients with rheumatoid arthritisArthritis & Rheumatism, 1983
- Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosusArthritis & Rheumatism, 1981
- Interaction between rheumatoid factor and antibody/DNA COMPLEXESArthritis & Rheumatism, 1981
- The Biology and Detection of Immune ComplexesPublished by Elsevier ,1980
- Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.Journal of Clinical Investigation, 1978
- Studies on the mechanism of solubilization of immune precipitates by serum.The Journal of Experimental Medicine, 1976
- A new complement function: solubilization of antigen-antibody aggregates.Proceedings of the National Academy of Sciences, 1975
- Activation of the Alternate Pathway of Human Complement by Rabbit CellsThe Journal of Immunology, 1974
- The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassayBiochemical Journal, 1973
- A Method of Trace Iodination of Proteins for Immunologic StudiesInternational Archives of Allergy and Immunology, 1966